M

Marinus Pharmaceuticals

D
MRNS
USD
0.0195
(5.8174%)
Market Closed
26,483.00
Volume
-2.03
EPS
-
Div Yield
-0.133346
P/E
19,538,308.28
Market Cap
Today
10.8438%
1 Week
16.257%
1 Month
-80.775%
6 Months
-77.263%
12 Months
-94.560%
Year To Date
-96.740%
All Time
0%

Title:
Marinus Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
Do you need help or have a question?